ClinicalTrials.Veeva

Menu

Heart and Blood Pressure Study: The Effect of Aortic Impedance on Myocardial Relaxation

University of Wisconsin (UW) logo

University of Wisconsin (UW)

Status

Completed

Conditions

High Blood Pressure

Treatments

Drug: oral hydralazine and intravenous nesiritide

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00204984
K23 AGO01022
H-2004-0382

Details and patient eligibility

About

Does dilation of blood vessels (vasodilation), which decreases aortic stiffness, have a greater effect on heart myocardium relaxation (diastole) than vasodilation which affects mean pressure equally without improving aortic stiffness?

Full description

60 subjects, 30 with hypertension and 30 without will attend two visits to the GCRC. At each visit, pulsatile hemodynamics (by using tonometry-a non-invasive means to obtain arterial pressure tracings) and Doppler tissue imaging relaxation velocity (a measurement of myocardial relaxation obtained by echocardiography) data will be collected before and after administration of vasodilator medication. At the first visit, each patient will receive an oral dose of the vasodilator hydralazine (does not effect aortic stiffness), and at the second visit each patient will receive intravenous nesiritide (does effect aortic stiffness). The relationship between timing of the reflected pulse wave and myocardial relaxation velocity will be studied at baseline and following administration of each vasodilator to determine if changing aortic stiffness has an impact on myocardial relaxation.

Enrollment

17 patients

Sex

All

Ages

65+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subjects over the age of 65

Exclusion criteria

  • Have known or suspected coronary artery disease
  • Have known or suspected left ventricular dysfunction
  • Have significant valvular, infiltrative, pericardial, or congenital heart disease
  • Have a resting systolic blood pressure < 100 mmHg
  • Have had an adverse reaction to nesiritide or hydralazine
  • Have a serum creatinine > 2 mg/dl at Visit 1

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems